Cargando…
The molecular basis of the neutralization breadth of the RBD-specific antibody CoV11
SARS-CoV-2, the virus behind the COVID-19 pandemic, has changed over time to the extent that the current virus is substantially different from what originally led to the pandemic in 2019–2020. Viral variants have modified the severity and transmissibility of the disease and continue do so. How much...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272436/ https://www.ncbi.nlm.nih.gov/pubmed/37334379 http://dx.doi.org/10.3389/fimmu.2023.1178355 |
_version_ | 1785059494095486976 |
---|---|
author | Tolbert, William D. Chen, Yaozong Sun, Lulu Benlarbi, Mehdi Ding, Shilei Manickam, Rohini Pangaro, Emily Nguyen, Dung N. Gottumukkala, Suneetha Côté, Marceline Gonzalez, Frank J. Finzi, Andrés Tehrani, Zahra R. Sajadi, Mohammad M. Pazgier, Marzena |
author_facet | Tolbert, William D. Chen, Yaozong Sun, Lulu Benlarbi, Mehdi Ding, Shilei Manickam, Rohini Pangaro, Emily Nguyen, Dung N. Gottumukkala, Suneetha Côté, Marceline Gonzalez, Frank J. Finzi, Andrés Tehrani, Zahra R. Sajadi, Mohammad M. Pazgier, Marzena |
author_sort | Tolbert, William D. |
collection | PubMed |
description | SARS-CoV-2, the virus behind the COVID-19 pandemic, has changed over time to the extent that the current virus is substantially different from what originally led to the pandemic in 2019–2020. Viral variants have modified the severity and transmissibility of the disease and continue do so. How much of this change is due to viral fitness versus a response to immune pressure is hard to define. One class of antibodies that continues to afford some level of protection from emerging variants are those that closely overlap the binding site for angiotensin-converting enzyme 2 (ACE2) on the receptor binding domain (RBD). Some members of this class that were identified early in the course of the pandemic arose from the V(H) 3-53 germline gene (IGHV3-53*01) and had short heavy chain complementarity-determining region 3s (CDR H3s). Here, we describe the molecular basis of the SARS-CoV-2 RBD recognition by the anti-RBD monoclonal antibody CoV11 isolated early in the COVID-19 pandemic and show how its unique mode of binding the RBD determines its neutralization breadth. CoV11 utilizes a heavy chain V(H) 3-53 and a light chain V(K) 3-20 germline sequence to bind to the RBD. Two of CoV11’s four heavy chain changes from the V(H) 3-53 germline sequence, [Formula: see text] to Ile and [Formula: see text] to Arg, and some unique features in its CDR H3 increase its affinity to the RBD, while the four light chain changes from the V(K) 3-20 germline sequence sit outside of the RBD binding site. Antibodies of this type can retain significant affinity and neutralization potency against variants of concern (VOCs) that have diverged significantly from original virus lineage such as the prevalent omicron variant. We also discuss the mechanism by which V(H) 3-53 encoded antibodies recognize spike antigen and show how minimal changes to their sequence, their choice of light chain, and their mode of binding influence their affinity and impact their neutralization breadth. |
format | Online Article Text |
id | pubmed-10272436 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102724362023-06-17 The molecular basis of the neutralization breadth of the RBD-specific antibody CoV11 Tolbert, William D. Chen, Yaozong Sun, Lulu Benlarbi, Mehdi Ding, Shilei Manickam, Rohini Pangaro, Emily Nguyen, Dung N. Gottumukkala, Suneetha Côté, Marceline Gonzalez, Frank J. Finzi, Andrés Tehrani, Zahra R. Sajadi, Mohammad M. Pazgier, Marzena Front Immunol Immunology SARS-CoV-2, the virus behind the COVID-19 pandemic, has changed over time to the extent that the current virus is substantially different from what originally led to the pandemic in 2019–2020. Viral variants have modified the severity and transmissibility of the disease and continue do so. How much of this change is due to viral fitness versus a response to immune pressure is hard to define. One class of antibodies that continues to afford some level of protection from emerging variants are those that closely overlap the binding site for angiotensin-converting enzyme 2 (ACE2) on the receptor binding domain (RBD). Some members of this class that were identified early in the course of the pandemic arose from the V(H) 3-53 germline gene (IGHV3-53*01) and had short heavy chain complementarity-determining region 3s (CDR H3s). Here, we describe the molecular basis of the SARS-CoV-2 RBD recognition by the anti-RBD monoclonal antibody CoV11 isolated early in the COVID-19 pandemic and show how its unique mode of binding the RBD determines its neutralization breadth. CoV11 utilizes a heavy chain V(H) 3-53 and a light chain V(K) 3-20 germline sequence to bind to the RBD. Two of CoV11’s four heavy chain changes from the V(H) 3-53 germline sequence, [Formula: see text] to Ile and [Formula: see text] to Arg, and some unique features in its CDR H3 increase its affinity to the RBD, while the four light chain changes from the V(K) 3-20 germline sequence sit outside of the RBD binding site. Antibodies of this type can retain significant affinity and neutralization potency against variants of concern (VOCs) that have diverged significantly from original virus lineage such as the prevalent omicron variant. We also discuss the mechanism by which V(H) 3-53 encoded antibodies recognize spike antigen and show how minimal changes to their sequence, their choice of light chain, and their mode of binding influence their affinity and impact their neutralization breadth. Frontiers Media S.A. 2023-06-02 /pmc/articles/PMC10272436/ /pubmed/37334379 http://dx.doi.org/10.3389/fimmu.2023.1178355 Text en Copyright © 2023 Tolbert, Chen, Sun, Benlarbi, Ding, Manickam, Pangaro, Nguyen, Gottumukkala, Côté, Gonzalez, Finzi, Tehrani, Sajadi and Pazgier https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Tolbert, William D. Chen, Yaozong Sun, Lulu Benlarbi, Mehdi Ding, Shilei Manickam, Rohini Pangaro, Emily Nguyen, Dung N. Gottumukkala, Suneetha Côté, Marceline Gonzalez, Frank J. Finzi, Andrés Tehrani, Zahra R. Sajadi, Mohammad M. Pazgier, Marzena The molecular basis of the neutralization breadth of the RBD-specific antibody CoV11 |
title | The molecular basis of the neutralization breadth of the RBD-specific antibody CoV11 |
title_full | The molecular basis of the neutralization breadth of the RBD-specific antibody CoV11 |
title_fullStr | The molecular basis of the neutralization breadth of the RBD-specific antibody CoV11 |
title_full_unstemmed | The molecular basis of the neutralization breadth of the RBD-specific antibody CoV11 |
title_short | The molecular basis of the neutralization breadth of the RBD-specific antibody CoV11 |
title_sort | molecular basis of the neutralization breadth of the rbd-specific antibody cov11 |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272436/ https://www.ncbi.nlm.nih.gov/pubmed/37334379 http://dx.doi.org/10.3389/fimmu.2023.1178355 |
work_keys_str_mv | AT tolbertwilliamd themolecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT chenyaozong themolecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT sunlulu themolecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT benlarbimehdi themolecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT dingshilei themolecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT manickamrohini themolecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT pangaroemily themolecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT nguyendungn themolecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT gottumukkalasuneetha themolecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT cotemarceline themolecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT gonzalezfrankj themolecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT finziandres themolecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT tehranizahrar themolecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT sajadimohammadm themolecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT pazgiermarzena themolecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT tolbertwilliamd molecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT chenyaozong molecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT sunlulu molecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT benlarbimehdi molecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT dingshilei molecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT manickamrohini molecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT pangaroemily molecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT nguyendungn molecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT gottumukkalasuneetha molecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT cotemarceline molecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT gonzalezfrankj molecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT finziandres molecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT tehranizahrar molecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT sajadimohammadm molecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 AT pazgiermarzena molecularbasisoftheneutralizationbreadthoftherbdspecificantibodycov11 |